<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050984</url>
  </required_header>
  <id_info>
    <org_study_id>BASBP</org_study_id>
    <secondary_id>2012CB517805</secondary_id>
    <nct_id>NCT02050984</nct_id>
  </id_info>
  <brief_title>Effect of Bariatric Surgery on Blood Pressure</brief_title>
  <acronym>BASBP</acronym>
  <official_title>A Prospective Study on the Effects of Bariatric Surgery on Blood Pressure in Patients With Obesity and Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhiming Zhu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bariatric surgery is generally recommended for obese people with a body mass index (BMI) of
      at least 40kg/m2, and for people with BMI 35 kg/m2 and serious coexisting medical conditions
      such as diabetes. A variety of studies showed that it cause significant weight loss, recovery
      from diabetes and improvement in cardiovascular risk factors, such as blood pressure. The
      recent guidelines suggest that patients with a BMI of more than 30 kg/m2 with co morbidities
      is a candidate for bariatric surgery. However, the patients with diabetes in Chinese has
      lower BMI than that in west country. Therefore, this research is designed to observe whether
      bariatric surgery reduce blood pressure in patients with diabetes and relatively lower BMI.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of hypertension medication prescription</measure>
    <time_frame>12 months</time_frame>
    <description>Reduction of hypertension medication prescription related to the baseline hypertension treatment at 12 months after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of hypertension medication prescription</measure>
    <time_frame>1 month to 6 months</time_frame>
    <description>Reduction of hypertension medication prescription compared to the baseline hypertension treatment at 1, 3 and 6 months.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from baseline in systolic blood pressure</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in diastolic blood pressure</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in body weight</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in body mass index</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in waist circumference</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in body fat distribution</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in fasting plasma glucose</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in fasting plasma insulin</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in HbA1c</measure>
    <time_frame>3 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in total cholesterol</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in LDL-cholesterol</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in HDL-cholesterol</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in triglycerides</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in artery vasodilative function</measure>
    <time_frame>1 to 12 months</time_frame>
    <description>Endothelium-dependent nitroglycerin(NTG)-induced dilatation and flow-mediated dilatation (FMD) by non-invasive high-resolution ultrasound.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in serum amino acids level</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in sense of taste</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in hepatic enzymes</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in serum creatine</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in serum electrolyte</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in complete blood count</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 to 12 months</time_frame>
  </other_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with obesity and diabetes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults aged between 18 and 60 years old.

          -  Type 2 Diabetes diagnosis defined according to WHO 2006 guideline.

          -  Body mass index between 25.0 and 39.9 kg/m2.

        Exclusion Criteria:

          -  Hypertension â‰¥ 180/120 mmHg;

          -  Type 1 diabetes, other types of diabetes or gestational diabetes;

          -  Acute complications of diabetes;

          -  Cerebrovascular diseases in the last 6 months.

          -  Cardiovascular diseases (myocardial infarction, angina, cardiac failure) in the last 6
             months.

          -  Baseline psychiatric disorders: schizophrenia, bipolar disorder, severe depression,
             psychosis.

          -  Renal diseases: diabetic nephropathy, creatinine clearance &lt; 30 ml/min.

          -  Advanced peripheral arterial disease

          -  Atrophic gastritis

          -  Alcoholism or use of illicit drugs

          -  Previous laparotomy

          -  Severe hepatic disorders

          -  Pregnancy or women not using effective contraceptive methods.

          -  Recent neoplasm (&lt; 5 years)

          -  Immunosuppressant drugs

          -  Unable to understanding and follow the study protocol orientations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hongbo He, MD.</last_name>
    <phone>86-23-69757880</phone>
    <email>cqhehongbo@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhiming Zhu, MD., PhD.</last_name>
    <phone>86-23-68767881</phone>
    <email>zhuzm@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo He, MD.</last_name>
      <phone>86-23-68757880</phone>
      <email>cqhehongbo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Zhiming Zhu, MD.,PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>January 29, 2014</last_update_submitted>
  <last_update_submitted_qc>January 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Zhiming Zhu</investigator_full_name>
    <investigator_title>Director of the Dept. of Hypertension &amp; Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Bariatric Surgery</keyword>
  <keyword>Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

